Diabetes Prevention Program Reauthorization Act of 2026
Sponsored By: Representative De La Cruz, Monica [R-TX-15]
Introduced
Summary
Reauthorizes the National Diabetes Prevention Program with fixed annual funding. This bill would convert the program's open-ended authorization into a five-year schedule of explicit yearly funding for FY2027–FY2031.
Show full summary
- People at risk of type 2 diabetes and their families would see continued statutory support for prevention services. The bill authorizes yearly funding that rises from $39.3 million in FY2027 to $59.3 million in FY2031.
- State and local public health agencies and program providers would get clearer, year-by-year funding authorizations to guide planning and delivery.
- The bill replaces an open-ended authorization with explicit annual amounts but leaves actual funding to be provided through later appropriations.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
More funding for diabetes prevention
This bill would reauthorize the National Diabetes Prevention Program and set specific authorized funding for FY2027–FY2031. It would authorize $39,300,000 for FY2027; $44,300,000 for FY2028; $49,300,000 for FY2029; $54,300,000 for FY2030; and $59,300,000 for FY2031. If enacted, these amounts would authorize funds to support program administration, providers, states, and participants. The funding would begin upon enactment but would remain subject to future annual appropriations.
Sponsors & CoSponsors
Sponsor
De La Cruz, Monica [R-TX-15]
TX • R
Cosponsors
Rep. Correa, J. Luis [D-CA-46]
CA • D
Sponsored 8/13/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov